Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Canada is not a "free-rider" on U.S. drug research, expert says.


ITHACA Ithaca, city, United States
Ithaca (ĭth`əkə), city (1990 pop. 29,541), seat of Tompkins co., S central N.Y., at the southern end of Cayuga Lake, in the Finger Lakes region; settled 1789, inc. as a city 1888.
. N.Y. -- Canada, Britain and Europe, are not "free riders Free rider

A follower who avoids the cost and expense of finding the best course of action simply by mimicking the behavior of a leader who made these investments.
" on U.S. patients and taxpayers, as the U.S. pharmaceutical industry claims. Pharmaceutical industry expert Donald Light (and supporter of President George W. Bush) told the Cornell Medical College. Nor are these lower prices a disincentive dis·in·cen·tive  
n.
Something that prevents or discourages action; a deterrent.


disincentive
Noun

something that discourages someone from behaving or acting in a particular way

Noun 1.
 to research.

In a special lecture Light reported on research that he and York University York University, at North York, Ont., Canada; nondenominational; coeducational; founded 1959 as an affiliate of the Univ. of Toronto, became independent 1965.  Professor Joel Lexcin conducted. Using data from the pharmaceutical industry, they found that:

* all R&D costs are fully recovered each year at British and Canadian prices.

* R&D budgets in Canada and all Western European countries have steadily risen "every year as far back as one wants to look, and they are still rising."

* American pharmaceutical researchers have discovered fewer new major drugs than one would expect based on their size and proportion of the world market.

The efforts of the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  will raise prices of patented drugs with trading partners through Free Trade Agreements and to lock in the high prices of the U.S. market.

Light calculates that the pharmaceutical industry devotes only 1.7 cents of every dollar to basic research, net of taxpayers' contributions. Light is a member of the Republican Business Advisory Council and professor at the University of Medicine and Dentistry of New Jersey The University of Medicine and Dentistry of New Jersey is the state-run health sciences institution of New Jersey and comprises eight distinct academic units: the New Jersey Medical School, the New Jersey Dental School, the Graduate School of Biomedical Sciences, the School of . The lecture is entitled, "In the Name of Research: Raising Prices Here and Abroad." 609-915-1588
COPYRIGHT 2005 Community Action Publishers
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Health
Publication:Community Action
Date:Jan 24, 2005
Words:230
Previous Article:Saskatchewan reviews addiction strategies.
Next Article:Ontario judge orders detained patient moved for psychiatric treatment.
Topics:



Related Articles
Rebif and Avonex go head-to-head.
Pfizer forum.
Prescription panic: How the anthrax scare challenged drug patents.
Drugs in Drinking Water: Are antibiotic-resistant superbugs evolving? (EH Update).
Consumers, states challenge federal ban on drug imports.
The changing landscape of pharmaceutical medicine.
Crossing borders: importing prescription drugs, illegally or legally, into the United States isn't expected to have a significant short-term impact...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles